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ABSTRACT
The 60kD heat shock protein (hsp60) is a highly conserved protein and a dominant antigen of
most pathogenic bacteria. In some women, chronic or repeated upper genital tract infections with
Chlamydia trachomatis, and possibly with other microorganisms, induces immune sensitization to
epitopes of hsp60 that are present in both the microbial and human hsp60. Once a woman becomes
sensitized to these conserved epitopes, any subsequent induction of human or bacterial hsp60
expression will reactivate hsp60-sensitized lymphocytes and initiate a pro-inflammatory immune
response. Hsp60 is expressed during the early stages of pregnancy, by both the embryo and the
maternal decidua. We examined, therefore, whether women who were sensitized to hsp60 experi-
enced less successful pregnancy outcomes compared to women who were not sensitized to this
antigen. In women undergoing in vitro fertilization (IVF), the presence of cervical IgA antibodies
reactive with the C. trachomatis hsp60 correlated with implantation failure after embryo transfer.
Further analysis revealed that an immunodominant epitope for these IgA antibodies was an hsp60
epitope shared between C. trachomatis and man. In subsequent studies of women not undergoing
IVF, cervical IgA antibodies to the human hsp60 were identified in 13 of 91 reproductive age
women. This antibody was most prevalent in those women with a history of primary infertility
(p 0.003). In addition, cervical anti-hsp60 IgA correlated with the detection of the pro-inflamma-
tory cytokines interferon-/ (p 0.001) and tumor necrosis factor-{x (p 0.02) in the cervix.
Conversely, women with proven fertility had the highest prevalence of the anti-inflammatory cyto-
kine, interleukin 10, in their cervices (p 0.001). In an analysis of serum samtles in a third study,
women with a history oftwo or more consecutive first trimester spontaneous abortions had a higher
prevalence (p 0.01) of IgG antibodies to the human hsp60 (36.8%) than did age matched fertile
women (11.1%) or women with primary infertility (11.8%). Immune sensitization to epitopes ex-
pressed by the human hsp60 may reduce the probability of a successful pregnancy outcome due to
reactivation of hsp60-reactive lymphocytes, induction of a pro-inflammatory cytokine response and
interference with early embryo development and/or implantation. (C) 1996 Wiley-Liss, Inc.
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ost bacteria share a dominant antigenic deter-
minant, designated "common antigen." Sub-
sequent studies revealed that this antigen is a
member of the 60kD family of heat shock proteins
(hsp60). All other organisms, including mammals,
also possess a homologous protein with a related
amino acid sequence. Hsp60 functions to prevent
the hydrophobic surfaces of unfolded or partially
folded nascent proteins from forming nonspecific
intracellular aggregates and to promote the proper
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folding of polypeptide chains. Under conditions of
rapid cell growth or differentiation, or following ex-
posure to an environmental stress such as inflamma-
tion, fever or toxic chemicals, hsp60 synthesis is
increased. By preventing protein denaturation and
inappropriate aggregation, the ability of the cell to
survive the stress is maximized,
Despite the highly conserved nature throughout
evolution of the hsp60 amino acid sequence, bacte-
rial hsp60 is highly immunogenic in man. Typi-
cally, following an acute infection immunity is re-
stricted to hsp60 epitopes that are specific to
microorganisms. However, prolonged or repeated
exposure to bacterial hsp60, such as might occur
during an asymptomatic Chlamydia trachomatis up-
per genital tract infection, can trigger immunity to
conserved hsp60 epitopes that are also expressed
in man.
4-6 Immune sensitization to conserved hsp60
epitopes may facilitate an autoimmune response to
selfhsp60. The pathogenesis ofdiabetes in the non-
obese diabetic mouse and adjuvant arthritis in rats
involve an autoimmune response to hsp60.
We have been exploring the consequences of
immune sensitization to hsp60 for fertility in
women. Heat shock proteins are among the first
proteins produced during embryogenesis, corre-
sponding to a time of rapid development. Epithelial
cells in the human decidua also express hsp60.1 In
addition, a murine hybridoma specific for hsp60
has been shown to react with human trophoblast
11
suggesting hsp60-related expression by this tissue.
Occlusion of the fallopian tubes subsequent to a
chlamydial infection has been attributed to an im-
mune response to the chlamydial hsp60.4,1z Among
women undergoing in vitro fertilization (IVF) the
presence of cervical IgA antibodies to chlamydial
hsp60 was associated with a failure of implantation
after embryo transfer.
13
Here we present further analyses of the relation
between fertility and immune sensitization to the
human hsp60.
MATERIALS AND METHODS
Subjects
Several different groups of subjects were studied:
Group A.
This group included 122 women undergoing IVF.
Analysis of samples from these women for IgA anti-
bodies to chlamydial hsp60 and C. trachomatis struc-
tural antigens has previously been reported.
3 IgA
antibodies to the chlamydial hsp60 were present in
24 of these women
Group B.
In this group were 72 women seeking treatment for
unexplained infertility, 12 women who had never
tried to conceive and 7 women with proven fertility.
Among the infertile women, 44 had primary infertil-
ity while 28 had at least one child with her present
partner. All subjects were married and in monoga-
mous relationship.
Group C.
This group had 38 women with no live births and
a history of at least two consecutive first trimester
spontaneous abortions (mean age 37.9 years), 34
female partners of couples with primary infertility
of at least three years duration whose husbands had
normal semen parameters (mean age 35.7 years) and
36 women with no history of spontaneous abortions
who had a live singleton birth within the past three
years and who conceived after less than 12 months
of attempting to conceive (mean age 35.9 years).
The aborter group consisted of 8 women with two
abortions, 20 with three abortions, 8 with four abor-
tions and two with greater than four abortions.
Samples
Endocervical samples were obtained from subjects
in group A at the time of oocyte retrieval and from
group B at mid-cycle. A Dacron swab was inserted
into the endocervix, twirled and removed into a
tube containing 0.5 ml phosphate-buffered saline
(PBS). The liquid was extruded from the swab, the
sample microcentrifuged and the supernatants were
frozen at -80C until used. Serum samples only
were obtained from subjects in group C.
Synthetic Peptide Epitopes of hsp60
Previous studies have demonstrated that sera from
women with chlamydial infections recognized 13
peptide epitopes of the chlamydial hsp60.
4 Each
of these peptides was synthesized and biotinylated
(Chiton Mimotopes, Clayton, Australia) employing
a spacer arm at the amino end and an amide at the
carboxy terminal. The peptides were reconstituted
in 0.2 ml 100% dimethyl sulfoxide, diluted 1:100
in PBS containing 0.1% bovine serum albumin
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(BSA) and 0.1% sodium azide and stored in aliquots
at 80C.
Anti-peptide Antibody Detection
The biotinylated peptides were diluted 1:10 in
PBS-0.1% BSA-0.1% sodium azide and 0.1 ml (1.0
g) added to wells of a microtiter plate containing
bound streptavidin. The plate was incubated on a
shaker for 60 min at room temperature, and the
wells washed four times with PBS-0.1% Tween 20
detergent (PBS-Tween). The cervical samples from
group A patients were diluted 1:10 in PBS-2% BSA-
0.1% azide and added to the wells. After 120 min
at room temperature the wells were washed four
times with PBS-Tween and 0.2 ml of a 1:200 dilu-
tion of horseradish peroxidase-labelled antibody to
human IgA in PBS-2% BSA was added. After a 60
min incubation the wells were washed four times
with PBS-Tween followed by two additional
washes with PBS. The peroxidase substrate, 2,21-
azino-di[3-ethylbenzothiazoline sulphonate] and
HzOz in 0.1M phosphate/0.08M citrate buffer, pH
4.0 was then added. After 60 min the optical density
of each well was determined at 405 nm. Utilizing
cervical samples from 98 women previously shown
to lack IgA antibodies to intact chlamydial hsp60,
a mean optical density value plus two standard devi-
ations of between 0.30 and 0.33 was obtained with
each of the peptides. Therefore, a cervical sample
was scored as positive for IgA antibody to a synthetic
peptide if it yielded an optical density > 0.35.
Antibodies to Human hsp60
Recombinant human hsp60 (StressGen, Victoria,
B.C.) was diluted to 10 Ixg/ml in 0.1M carbonate
buffer, pH 9.8 and 0.1 ml added to wells ofa microti-
ter plate. After an overnight incubation at 4C the
wells were washed four times with PBS-Tween.
Aliquots (0.1 ml) of cervical samples (group B), di-
luted 1:5 in PBS-Tween, or sera (group C), diluted
1:160, were added to the wells and the plate floated
on a 37C water bath for 60 min. The wells were
then washed and incubated with a 1:500 dilution
of alkaline phosphatase (AP)-conjugated goat anti-
body to human IgA (cervical samples) or a 1:200
dilution of AP-conjugated goat antibody to human
IgG (serum samples). Following an additional 37C
60 min incubation the wells were washed as above
and the colorless AP substrate, p-nitrophenylphos-
phate in 10% diethanolamine buffer was added.
After a 30-60 min room temperature incubation
the appearance of a yellow color in the wells was
quantitated at 405 nm. Known positive and negative
samples were always assayed in parallel to the test
samples. Inter- and intra-assay variations were
< 10%. A positive sample was defined as one yield-
ing an optical density value that was at least two
standard deviations above the mean value obtained
with a panel of samples from subjects of proven
fertility and no history of abortions or genital
tract infections.
Cytokine Assays
Cervical samples (group B) were diluted 1:4 and
utilized in immunoassays using commercially avail-
able ELISA kits (BioSource International, Cama-
rillo, CA) for detection of tumor necrosis factor-x
(TNFci), interferon-y (IFNy) and interleukin 10
(ILl0). Replicate analyses differed by less than
10%.
Statistics
Fisher’s exact test was utilized to examine differ-
ences in discrete variables among the groups of
subjects. Differences in cervical IgA binding to each
of the synthetic peptides were evaluated by the
nonparametric Wilcoxon rank sums test. Ap value
<0.05 was considered significant.
RESULTS
Cervical Immunity to a Conserved Epitope of
the Chlamydial hsp60
A single immunodominant epitope, comprising
amino acids 260-271 of the C. trachomatis hsp60, was
identified by antibodies present in cervical samples
from the IVF subjects (Table 1). More women pre-
viously shown to be sensitized to the intact chla-
mydial hsp60 had cervical IgA antibodies to this
peptide than to any of the other peptides. In addi-
tion, this peptide yielded the highest mean optical
density in the ELISA detection assay (p < 0.05).
Cervical immunity to peptide 260-271 was iden-
tified in 21 (87.5%) of the 24 women with, and in
only 6 (6.1%) of the 91 women without, antibodies
to intact hsp60 (p < 0.0001). As an immunological
marker for detection of cervical IgA antibodies to
chlamydial hsp60, peptide 260-271 antibodies had a
sensitivity of87.5%, a specificity of93.9%, a positive
predictive value of 77.8% and a negative predictive
value of 96.8%.
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TABLE I. Cervical IgA antibodies to synthetic peptides corresponding to epitopes of the C. trachomatis hsp60
in women undergoing IVF who were positive for antibodies to intact hsp60
Amino acid Amino acid Mean optical
sequence positions No. Positive (%) density (S.D.)
VTLGPKGRHVVI 29-40 15 (62.5) .389 (.
VLAEAIYTEGLR 94-105 12 (50.0) .359 (.
SANNDAEIGNLI 151-162 9 (37.5) .321 (.
DVVDGMNFNRGY 188-199 16 (66.7) .389 (.
SGIKDFLPVLQQ 228-239 14 (58.3) .358 (.
ATLVGNRIRGGF 260-271 21 (87.5) .463 (.
GDRRKAMFEDIA 282-293 10 (41.7) .340 (.
ILPGGGTALIRC 411-422 14 (58.3) .381 (.
NEDEQIGARIVL 435-446 II (45.8) .348 (.
SAPLKQIAANAG 450-461 12 (50.0) .358 (.
NAGKEGAIIFQQ 459-470 17 (70.8) .394 (.
GAIIFQQVMSRS 464-475 15 (62.5) .398 (.
QVMSRSANEGYD 470-481 18 (75.0) .391 (.
34)
26)
03)
5)
24)
75)*
18)
16)
20)
3)
52)
36)
50)
*P < .05 vs. any other peptide.
The relation between IVF outcome and cervical
immunity to peptide 260-271 is shown in Table 2.
Women with this antibody had a significantly (p
0.03) increased prevalence of transient biochemical
pregnancies (22.2%) after embryo transfer than did
antibody-negative women (7.4%). Similarly, the
presence of anti-peptide 260-271 antibody corre-
lated with a decreased rate of term pregnancy
(11.1% vs. 30.5%, p 0.04). Women positive for
this antibody were significantly (p 0.03) older
(37.2 years) than the antibody negative women
(34.9 years ).
Cervical Immunity to the Human hsp60
Among the 91 non-IVF patients whose cervical sam-
ples were analyzed, 13 (14.3%) were positive for
IgA antibodies to the human hsp60. The presence
of this antibody correlated with detection of IFN
(p 0.001) and TNFo (p 0.02) in the cervical
samples (Table 3). In contrast, there was no relation
between cervical ILl0 and anti-hsp60 IgA.
The relation between cervical immunity to the
human hsp60 and pregnancy outcome in the sub-
jects studied is shown in Table 4. Women with
primary infertility had a significantly (p 0.003)
higher prevalence of cervical anti-hsp60 IgA (10 of
44, 22.7%) than did all of the other women (1 of
47, 2.1%). Among the cytokines, the only significant
difference noted (p 0.001) was a higher preva-
lence of cervical ILl0 among the fertile women
TABLE 2. Relation between outcome of IVF cycle
and cervical antibodies to synthetic peptide
260-271 of the chlamydial hsp60
IVF Outcome
IgA antibodies to
peptide 260-271
Number of patients (%)
Present Absent
No fertilization 4 (14.8) 6 (6.3)
Embryo transfer:
Not pregnant 12 (44.4) 48 (50.5)
Biochemical pregnancy 6 (22.2)* 7 (7.4)
Spontaneous abortion 2 (7.4) 5 (5.3)
Term birth 3 (I I. I)** 29 (30.5)
*p .03 vs. term births; **p .04 vs. term births.
(5 of 7, 71.4%) as opposed to women with either
primary or secondary infertility (9 of 72, 12.5%).
There was no relation between cervical immu-
nity to hsp60 and time since last sexual intercourse,
the presence of cervical antisperm antibodies or
detection of cervical Ureaplasma urealyticum orMyco-
plasma hominis.
Circulating IgG Antibodies to Human hsp60
and Fertility Status
At a serum dilution of 1:160 antibodies to the human
hsp60 were more prevalent in women with a history
of spontaneous abortions than in the fertile (p
0.01) or infertile (p 0.01) women (Table 5). This
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TABLE 3. Relation between cytokines and IgA
antibodies to the Human 60kD heat shock protein
in the cervix
No. positive/
Pair Total no. (%) p value
Hsp60 IgA in women with IFN-/
Hsp60 IgA in women without IFN-/
Hsp60 IgA in women with TNF-c
Hsp60 IgA in women without TNF-c
Hsp60 IgA in women with ILl0
Hsp60 IgA in women without ILl0
5/9 (55.6%) 0.001
8/91 (8.8%)
8/3 (25.8%) 0.02
5/69 (7.2%)
4/22 (I 8.2%) 0.4
9/78 (I 1.5%)
TABLE 4. Relation between IgA antibody to the
human 60kD heat shock protein and
pregnancy history
Pregnancy No. (%) with anti-
history No. subjects heat shock protein IgA
Primary infertility 44 10 (22.7)*,**
Secondary infertility 28 0
Fertile 7 1(14.3)
Conception not 12 0
attempted
*p 0.005 vs. secondary infertility; **p 0.003 vs. all others.
TABLE 5. IgG antibodies to the 60kD human heat
shock protein in sera from females
Group No. of women No (%) positive
Fertile 36 4 (I I. I)
Aborters 38 14 (36.8)*,**
Infertile 34 4 (I 1.8)
*p .016 vs. the infertile group; **p .014 vs. the fertile group.
antibody was present in 14 (36.8%) of the aborters,
4 (11.1%) of the fertile women and 4 (11.8%) of the
infertile women. Among the aborters, there was
no relation between the number of spontaneous
abortions and prevalence of anti-hsp60 IgG.
There was no relation between self-reported his-
tory of genital tract infections and serum anti-hsp60
IgG. It should be noted, however, that only 4women
reported a history ofC. trachomatis infection and none
had been infected with Neisseria gonorrhoeae. Simi-
larly, there was no relation between past mode of
contraception and prevalence of this antibody.
DISCUSSION
In the present study, the C. trachomatis hsp60 epi-
tope comprising amino acids 260-271 was shown to
be a dominant epitope recognized by immunocom-
petent cells in the genital tracts ofwomen undergo-
ing IVF. This agrees with and extends an earlier
study identifying the 201-300 amino acid region
of the chlamydial hsp60 as an immunodominant
epitope in infertile women.
15 Peptide 260-271 is a
highly conserved hsp60 epitope; a similar sequence
is present in the human hsp60 and antibodies to
the chlamydial epitope react with the corresponding
human epitope.
14
It is interesting to speculate on the consequences
for women of immune sensitization to hsp60 epi-
tope 260-271. Immunization of rats with an overlap-
ping hsp60 epitope, comprising amino acids 256-
269, led to a downregulation of pro-inflammatory
immune responses.
6 This suggests that immunity
to epitope 260-271 may similarly limit the magni-
tude of pro-inflammatory immune responses to
C. trachomatis in the female genital tract.
However, the existence ofimmune cells that are
sensitized to epitope 260-271 of the chlamydial
hsp60, and which also recognize the human hsp60,
may create complications in those instances where
human hsp60 expression occurs. The observed rela-
tionships between immune sensitization to epitope
260-271 and both an increased rate of embryo loss
after a transient implantation and a decreased preg-
nancy rate supports the hypothesis that an autoim-
mune response to the human hsp60 might contrib-
ute to adverse pregnancy outcome. Reactivation of
hsp60-sensitized lymphocytes by human hsp60 ex-
pression in the decidua or embryo
9, may interfere
with immune regulatory mechanisms essential to
the maintenance of the semi-allogeneic embryo and
induce immune rejection.
In subsequent studies we identified cervical IgA
antibodies to human hsp60 in the cervices of 14.3%
of 91 reproductive age women and demonstrated
an association between this immune sensitization
and both the presence of pro-inflammatory cyto-
kines IFN/and TNFo in the cervix and a diagnosis
of primary infertility.
Cytokines can be classified as enhancing cell-
mediated immunity (TH1 responses) or promoting
humoral immunity (TH2 responses). Both IFN/
and TNFot are TH cytokines while IL10 is a TH2
cytokinc which blocks pro-inflammatory cytokine
synthesis.
17 Since pro-inflammatory cytokines are
generally harmful to pregnancy, and TH2 cytokines
predominate at the maternal-fetal interface,
18 it has
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been hypothesized that maintenance of a TH2 im-
mune response is a prerequisite to a successful preg-
nancy outcome. 19 Our observation of an association
between endocervical IL10 and a history of fertility
supports this view and further suggests that TH2
predominance in the cervix may also preferentially
occur during the nonpregnant state. Therefore, the
observed association between cervical immunity to
human hsp60 and IFNy and TNFot expression
strongly implies that an immune response to hsp60
may favor TH1 cytokine expression and overcome
TH2 cytokine predominance.
Finally, systemic immunity to the human hsp60
was shown to be associated with first trimester spon-
taneous abortion. Binding of this antibody to hsp60
expressed on maternal or fetal cells, and the subse-
quent induction of pro-inflammatory cytokines
might account for this observation. Either a direct
impairment of cell viability or interference with
immune regulatory mechanisms could lead to an
unfavorable pregnancy outcome.
These observations reinforce the connection be-
tween immune sensitization to epitopes of the
hsp60 that are expressed in the human hsp60 and
adverse pregnancy outcome. Immunity to heat
shock proteins has also been observed in a number
of autoimmune diseases,z, el Microorganisms such
as C. trachomatis which induce asymptomatic infec-
tions, and which, therefore, tend to be chronic and
undetected, are prime candidates as inducers of
immunity to crossreacting conserved epitopes of
hsp60. Alternatively, immunity to the human hsp60
may also be directly induced by some noninfec-
tious event.
Additional prospective studies are required to
clarify the consequences of autoimmunity to the
human hsp60 in pregnant women. In addition, there
is a need to characterize the cellular locations of
hsp60 in maternal and fetal cells during early preg-
nancy. Such studies are in progress.
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